Overview

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma

Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
A randomised, double-blind, placebo-controlled (with rescue medication), multi-centre study to evaluate the efficacy and safety of inhaled fluticasone furoate in the treatment of persistent asthma in adults and adolescents not currently receiving inhaled corticosteroids
Phase:
Phase 3
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Fluticasone
Xhance